Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
365
-
Total 13F shares, excl. options
-
52.4M
-
Shares change
-
+1.42M
-
Total reported value, excl. options
-
$9.02B
-
Value change
-
+$259M
-
Put/Call ratio
-
0.68
-
Number of buys
-
178
-
Number of sells
-
-167
-
Price
-
$172.43
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2015
405 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q1 2015.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 365 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.4M shares
.
Largest 10 shareholders include FMR LLC (4.38M shares), VANGUARD GROUP INC (3.16M shares), SCOPIA CAPITAL MANAGEMENT LP (2.42M shares), BlackRock Fund Advisors (2.02M shares), LSV ASSET MANAGEMENT (1.97M shares), BlackRock Advisors LLC (1.65M shares), ACADIAN ASSET MANAGEMENT LLC (1.56M shares), DEUTSCHE BANK AG\ (1.52M shares), BlackRock Institutional Trust Company, N.A. (1.49M shares), and IRIDIAN ASSET MANAGEMENT LLC/CT (1.45M shares).
This table shows the top 365 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.